|
US6559138B1
|
|
3-Desoxy-vitamin D3 analog esters
|
|
US6979693B2
|
|
Pyrazole derivatives-p38 MAP kinase inhibitors
|
|
US6900220B2
|
|
Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
|
|
US6417186B1
|
|
Substituted-phenyl ketone derivatives as IP antagonists
|
|
US6518276B2
|
|
7-oxo-pyridopyrimidines (II)
|
|
US6506749B2
|
|
7-oxo-pyridopyrimidines (I)
|
|
US7141365B2
|
|
Methods for diagnosing a mucin production associated disease condition
|
|
US6515198B2
|
|
Use of purinergic receptor modulators and related reagents
|
|
US6472536B1
|
|
2-(substituted-phenyl)amino-imidazoline derivatives
|
|
US6339107B1
|
|
Methods for treatment of Emphysema using 13-cis retinoic acid
|
|
US6258819B1
|
|
Substituted 2(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)-4(3H)-azaquinazolinones
|
|
US6649377B1
|
|
Human aggrecanase and nucleic acid compositions encoding the same
|
|
US6733982B1
|
|
Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity
|
|
US6355641B1
|
|
Oxazolone derivatives and uses thereof
|
|
US6376506B1
|
|
Sulfamide-metalloprotease inhibitors
|
|
US6492394B1
|
|
Sulfonamide hydroxamates
|
|
US6197976B1
|
|
Preparation of ketorolac
|
|
US6335459B1
|
|
Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
|
|
US6309858B1
|
|
T-type calcium channel variants; compositions thereof; and uses
|
|
US6316466B1
|
|
Pyrazole derivatives P-38 MAP kinase inhibitors
|
